Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Christer Janson, Georgios Stratelis, Anna Miller-Larsson, Tim Harrison, Kjell Larsson
  • International Journal of Chronic Obstructive Pulmonary Disease, October 2017, Dove Medical Press
  • DOI: 10.2147/copd.s143656

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/copd.s143656

The following have contributed to this page: Christer Janson and Kjell Larsson